OXUR.BR
Price:
$0.96
Market Cap:
$1.41M
Oxurion NV, a biopharmaceutical company, develops and commercializes medicines for the treatment of eye diseases in Belgium and internationally. Its lead product is JETREA for the treatment of vitreomacular adhesion/vitreomacular traction. The company also develops THR-149, a plasma kallikrein inhibitor, which is in Phase II clinical trials for the treatment of diabetic macular edema (DME); and THR-687, an integrin antagonist which is in Phase II clinical trials for the treatment of DME. It has collaboration agreements with Bicycle Therapeutics, INC Research, and Galapagos NV. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV ...[Read more]
Industry
Biotechnology
IPO Date
2006-07-07
Stock Exchange
EURONEXT
Ticker
OXUR.BR
According to Oxurion NV’s latest financial reports and current stock price. The company's current Current Ratio is 0.14. This represents a change of -73.03% compared to the average of 0.52 of the last 4 quarters.
The mean historical Current Ratio of Oxurion NV over the last ten years is 6.03. The current 0.14 Current Ratio has changed 131.62% with respect to the historical average. Over the past ten years (40 quarters), OXUR.BR's Current Ratio was at its highest in in the June 2012 quarter at 24.15. The Current Ratio was at its lowest in in the September 2008 quarter at 0.
Average
6.03
Median
6.38
Minimum
0.14
Maximum
13.07
Discovering the peaks and valleys of Oxurion NV Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 31.03%
Maximum Annual Current Ratio = 13.07
Minimum Annual Increase = -75.71%
Minimum Annual Current Ratio = 0.14
Year | Current Ratio | Change |
---|---|---|
2023 | 0.14 | -75.71% |
2022 | 0.58 | -53.17% |
2021 | 1.23 | -65.06% |
2020 | 3.52 | -35.92% |
2019 | 5.49 | -42.44% |
2018 | 9.53 | 31.03% |
2017 | 7.28 | -6.28% |
2016 | 7.76 | -40.58% |
2015 | 13.07 | 11.26% |
2014 | 11.74 | -24.12% |
The current Current Ratio of Oxurion NV (OXUR.BR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0.65
5-year avg
2.19
10-year avg
6.03
Oxurion NV’s Current Ratio is less than Biocartis Group NV (2.15), less than Mithra Pharmaceuticals SA (0.90), less than MDxHealth SA (2.42), less than Celyad Oncology SA (3.79), less than argenx SE (8.53),
Company | Current Ratio | Market cap |
---|---|---|
2.15 | $27.24M | |
0.90 | $14.93M | |
2.42 | $85.63M | |
3.79 | $9.82M | |
8.53 | $29.16B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oxurion NV using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Oxurion NV or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Oxurion NV's Current Ratio?
How is the Current Ratio calculated for Oxurion NV (OXUR.BR)?
What is the highest Current Ratio for Oxurion NV (OXUR.BR)?
What is the 3-year average Current Ratio for Oxurion NV (OXUR.BR)?
What is the 5-year average Current Ratio for Oxurion NV (OXUR.BR)?
How does the current Current Ratio for Oxurion NV (OXUR.BR) compare to its historical average?